CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy

CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Détails bibliographiques
Auteur principal:	Eva, Israt Ara Jannat
Autres auteurs:	Rahman, Kazi Fatema
Format:	Thèse
Langue:	English
Publié:	Brac University 2023
Sujets:	CRISPR/Cas9 mechanism In vivo and in vitro modeling CRISPR/Cas9 delivery Mutation targeting in cancer and DMD Chromosomal rearrangement Mouse modeling Off-target limitation DMD mutation in human iPSCs Myoediting of DMD Therapeutic application of CRISPR Molecular genetics Cancer > Treatment
Accès en ligne:	http://hdl.handle.net/10361/17764

Documents similaires

A review on CRISPR-Cas system based applications in Oncology
par: Sadia, Mir
Publié: (2022)

CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
par: Maria, Amatul
Publié: (2020)

Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
par: Nwabunwanne, Eze Uchenna
Publié: (2022)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
par: Shaikat, Mahdi Mubin
Publié: (2023)

CRISPR/Cas9 genome editing to treat sickle cell disease
par: Ullah, Mohammad
Publié: (2023)

A review on CRISPR Technology as an Antiviral Tool
par: Srishti, Sanjida Ahmed
Publié: (2023)

A review paper on Nanotechnology based strategies in the treatment of cancer
par: Rahman, Samia
Publié: (2022)

Biased acquisition of spacers by the CRISPR System of the V. cholerae
par: Supan, Erena Tuzneen, et autres
Publié: (2021)

Analysis and comparison between the Genome of CRISPR bacteriophages
par: Muntaha, Mumtasin
Publié: (2021)

Distribution of complete CRISPR-Cas systems in vibrio cholerae and its effect on presence of plasmid derived contigs in complete genome assemblies
par: Reza, Ratul
Publié: (2024)

Trend in approval of targeted biologics in the last two decades
par: Siddika, Khadiza
Publié: (2024)

Exploring the possible function and acquisition pattern of self-targeting Spacers: in five common infectious bacteria
par: Kenneth, Mutebi John
Publié: (2019)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
par: Bristy, Israt Zerin
Publié: (2021)

A comprehensive in silico investigation into the pathogenic SNPs in RTEL1 gene and their biological consequences
par: Tanshee, Rifah Rownak
Publié: (2023)

The microbial models of molecular biology
par: Davis, Rowland H.

SIRT6 and cancer stem cells: is there any implication?
par: Sarker, Tanosi
Publié: (2022)

Assessing the interspecies and intraspecies diversity of Cas1 and Cas3 proteins of the CRISPR-Cas system in vibrio cholera and Escherichia coli strains
par: Tabassum, Tahani, et autres
Publié: (2022)

Exploring of deletion mutation causative for Duchenne Muscular Dystrophy (DMD) in Bangladesh cohort
par: Eshaque, Tamannyat Binte
Publié: (2024)

Genetic disorders associated with mutations in bHLH transcription factors: a review
par: Joya, Mollika Bharadwaj
Publié: (2023)

A review on targeted therapies for lung cancer
par: Ashraf, Anushey
Publié: (2023)

Molecules associated with the development of lung cancer
par: Rahman, Adree, et autres
Publié: (2023)

Inside the human genome
par: Avise, John C.

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
par: Nahar, Kamrun
Publié: (2023)

State of Thalassemia in Bangladesh: a review
par: Reedoy, Md. Shariqul Islam
Publié: (2022)

Carcinogenesis

Molecular biology of cancer : mechanisms, targets, and therapeutics /
par: Pecorino, Lauren
Publié: (2012)

Molecular biology of the gene /
Publié: (2004)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
par: Meem, Manila
Publié: (2023)

Introduction to genetic analysis /
Publié: (2012)

Targeted therapeutic options in the treatment of Breast Cancer
par: Alam, Kazi Tasnuva
Publié: (2022)

iGenetics : a molecular approach /
par: Russell, Peter J.
Publié: (2006)

Modern genetic analysis : integrating genes and genomes /
par: Griffiths, Anthony J. F.
Publié: (2002)

iGenetics : a molecular approach /
par: Russell, Peter J.
Publié: (2010)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
par: Paul, Pulock
Publié: (2024)

The current cancer situation in metropolitan Dhaka
par: Morshid, Golam
Publié: (2023)

Molecular biology and biotechnology : a guide for teachers /
par: Kreuzer, Helen
Publié: (2008)

Banking credit for farm inputs marketing business : macro perspective and micro realities / Bhupat M. Desai, N.V. Namboodiri.
par: Desai, B. M. 1938
Publié: (1996)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
par: Karim, Azrin
Publié: (2024)

Repurposing Albendazole and Mebendazole, an antiparasitic drug in treating colorectal cancer- a review
par: Mondal, Shawon
Publié: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
par: Tania, Umme
Publié: (2023)